Income tax expense · Fiscal year 2025
| 1 | Johnson & JohnsonJNJ | $5.8B |
|---|---|---|
| 2 | Eli LillyLLY | $5.1B |
| 3 | Novo Nordisk A SNVO | $4.3B |
| 4 | MerckMRK | $2.8B |
| 5 | AbbVieABBV | $2.4B |
| 6 | Bristol Myers SquibbBMY | $2.3B |
| 7 | AstraZenecaAZN | $2.2B |
| 8 | HCA HealthcareHCA | $2.1B |
| 9 | Abbott LaboratoriesABT | $1.9B |
| 10 | UnitedHealth GroupUNH | $1.9B |